Morphine Sulfate
- Product NDC
- 17856-0517
- 11-digit product format
- 178560517
- Labeler code
- 17856
- Product ID
- 17856-0517_6e52f354-e4bd-4fed-b733-14d48b06cd97
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Morphine Sulfate
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- NDA022195
- Marketing category
- NDA
- Marketing start
- 2008-03-17
- Marketing end
- 0000-00-00
- Substance
- MORPHINE SULFATE
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 17856-0517-1 | 2025-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-2 | 2025-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-3 | 2025-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-4 | 2025-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-1 | 2023-06-15 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-2 | 2023-06-15 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-3 | 2023-06-15 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-4 | 2023-06-15 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
| 17856-0517-4 | 2023-01-30 | C162847 | 48780-1 | f386c64a-04ac-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use MORPHINE SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for MORPHINE SULFATE ORAL SOLUTION. MORPHINE SULFATE oral solution, for oral use CII Initial U.S. Approval: 1941 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 17856-0517-1 | Morphine Sulfate | 60 in 1 BOX, UNIT-DOSE | SOLUTION | 60 | | 4 |
| 17856-0517-2 | Morphine Sulfate | 120 in 1 BOX, UNIT-DOSE | SOLUTION | 120 | | 4 |
| 17856-0517-3 | Morphine Sulfate | 120 in 1 BOX, UNIT-DOSE | SOLUTION | 120 | | 4 |
| 17856-0517-4 | Morphine Sulfate | 120 in 1 BOX, UNIT-DOSE | SOLUTION | 120 | | 4 |
| 17856-0517-5 | Morphine Sulfate | 0.25 mL in 1 SYRINGE | SOLUTION | 0.25 | | 4 |
| 17856-0517-6 | Morphine Sulfate | 1.0 mL in 1 SYRINGE | SOLUTION | 1.0 | | 4 |
| 17856-0517-7 | Morphine Sulfate | 0.25 mL in 1 SYRINGE | SOLUTION | 0.25 | | 4 |
| 17856-0517-8 | Morphine Sulfate | 1 mL in 1 SYRINGE | SOLUTION | 1 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 17856-0517 | MORPHINE SULFATE SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 4 | Legacy NDC, 8 package rows | 20230616_839923b4-4b4c-4745-baa5-4d27d4dbb5e7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 17856-0517-1 | 17856051701 | 60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0517-1) > .25 mL in 1 SYRINGE | 60 syringe | 2021-01-07 | 0000-00-00 | No | No | Current |
| 17856-0517-2 | 17856051702 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0517-2) > 1 mL in 1 SYRINGE | 120 syringe | 2021-01-07 | 0000-00-00 | No | No | Current |
| 17856-0517-3 | 17856051703 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0517-3) > .25 mL in 1 SYRINGE | 120 syringe | 2021-01-07 | 0000-00-00 | No | No | Current |
| 17856-0517-4 | 17856051704 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0517-4) > 1 mL in 1 SYRINGE | 120 syringe | 2021-03-10 | 0000-00-00 | No | No | Current |
| 17856-0517-5 | 17856051705 | 0.25 mL in 1 SYRINGE | 0.25 ml | | | | | Historical |
| 17856-0517-6 | 17856051706 | 1.0 mL in 1 SYRINGE | 1.0 ml | | | | | Historical |
| 17856-0517-7 | 17856051707 | 0.25 mL in 1 SYRINGE | 0.25 ml | | | | | Historical |
| 17856-0517-8 | 17856051708 | 1 mL in 1 SYRINGE | 1 ml | | | | | Historical |